Sie sind hier : Home > Diabetologie > News > Leistungsbeurteilung des Quo-Test®
Leistungsbeurteilung des Quo-Test® nach NGSP Kriterien
Leistungsbeurteilung des Quo-Test® nach NGSP-Kriterien und Sigma-Metriken durch Lenters-Westra, E., HbA1c-Forscher des Europäisches Laboratorium für Glykohämoglobin, Isala, Zwolle, Niederlande.
Quo Test bestand alle Tests erfolgreich
Zitat: “Bemerkenswerterweise zeigte der Quo-Test® keine Interferenz der häufigsten Hb-Varianten HbAS, HbAC, HbAD, HbAE, HbAJ, A2 erhöht (-Thalassämie) und HbF <8,6%“
Hier geht es zur Evaluation.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
